Compare HCA Health Inc (HCA) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Sana Biotechnology Inc — how do they compare? HCA Health Inc trades at $373.29 (market cap $82.17B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: HCA Health Inc is far larger — about 94× Sana Biotechnology Inc's market cap, and HCA Health Inc pays a 0.84% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals.
| HCA | SANA | |
|---|---|---|
Market Cap | $82.17B | $873.84M |
Sector | Health | Health |
52-Week High | $545.13 | $5.92 |
52-Week Low | $334.32 | $2.68 |
Enterprise Value | $131.08B | $848.03M |
Dividend Yield | 0.84% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $373.09, up 0.51% with bearish technical signals despite strong fundamentals. The company reported Q2 2026 preliminary revenue above expectations but cut full-year profit guidance, causing recent stock pressure. Analyst consensus remains bullish with a $469.40 price target, though multiple law firms are investigating potential securities law violations following the guidance revision.
Investment outlook balances strong operational performance against near-term headwinds. The stock offers value with a 12.76 P/E ratio and consistent earnings beats, but faces risks from rising expenses, payer mix challenges, and ongoing legal investigations. Institutional sentiment remains positive despite technical weakness and recent guidance concerns.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
